4.7 Article

Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

Alan Sandler et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Article Oncology

Treatment of metastatic renal cell carcinoma with a combination of bevacizumab and erlotinib

JD Hainsworth et al.

JOURNAL OF CLINICAL ONCOLOGY (2005)

Review Biotechnology & Applied Microbiology

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

N Ferrara et al.

NATURE REVIEWS DRUG DISCOVERY (2004)

Article Medicine, General & Internal

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

H Hurwitz et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)